Arkema Balanced Scorecard

Arkema Balanced Scorecard

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

Arkema Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Unlock the Full Balanced Scorecard for Deeper Strategic Insight

This Arkema Balanced Scorecard Analysis gives you a structured view of the company's financial, customer, internal process, and learning and growth priorities. The page already includes a real preview of the actual analysis, so you can review the content and format before buying. Purchase the full version to get the complete ready-to-use report.

Benefits

Icon

Segment Clarity

A Balanced Scorecard gives Arkema a clean, like-for-like view across its 3 main segments: Adhesive Solutions, Advanced Materials, and Coating Solutions. That matters because these units sell into different end markets, so one revenue line can hide where margin, growth, or execution is really improving. In 2025, that segment-level lens helps management spot which businesses are carrying the mix and which need more capital or fixes.

Icon

Innovation Discipline

Innovation discipline matters for Arkema because sustainable products must turn R&D spend into revenue, not just patents. In 2025, track new-product sales, development cycle time, and launch milestones to see whether ideas move fast enough to market. That keeps the Balanced Scorecard tied to cash flow and growth, not lab activity alone.

Explore a Preview
Icon

Plant Execution

Plant execution helps Arkema tighten discipline across about 150 sites in more than 40 countries, where small losses in yield or uptime can hit specialty materials margins fast. In 2025, the scorecard can track yield, uptime, safety, energy intensity, and on-time delivery in one view, so site teams react faster and waste less.

It also links daily plant control to financial results, because every point of better uptime or lower energy use lifts output and protects service levels. For a global chemicals network, that makes execution a direct lever for cost, safety, and customer reliability.

Icon

Customer Proximity

Arkema's 2025 customer base spans construction, automotive, electronics, and consumer goods, so a Balanced Scorecard should track more than shipment volume. Customer proximity is strongest when it measures technical service response, complaint closure time, retention, and application success, because these show whether Arkema is helping customers solve process and performance issues. That matters in specialty materials, where a fast fix can protect repeat orders and reduce churn.

Icon

Capital Focus

Capital Focus keeps Arkema's strategy tied to capital spending, cash conversion, and return on invested capital, so managers can rank projects by payback, not just growth. That matters for Arkema because its specialty materials business relies on specialized plants and long-lived production systems, where one weak investment can drag returns for years. For investors, that discipline is practical and easier to trust.

Icon

Arkema's Scorecard Turns Operations Into Profit Signals

Arkema's Balanced Scorecard makes benefits visible by tying 3 segments, about 150 sites, and more than 40 countries to faster fixes, better mix, and tighter capital use. In 2025, that helps management link new-product sales, uptime, energy use, and customer response to profit, not just activity.

Benefit 2025 signal
Execution Uptime, yield
Growth New-product sales
Returns ROIC, cash conversion

What is included in the product

Word Icon Detailed Word Document
Analyzes Arkema's strategic performance across financial, customer, internal process, and learning and growth priorities
Plus Icon
Excel Icon Editable Excel File
Provides a concise Arkema Balanced Scorecard view to quickly identify performance gaps across financial, customer, process, and growth priorities.

Drawbacks

Icon

KPI Overload

Arkema's Balanced Scorecard can get crowded fast because it spans 3 major segments and many end markets, so managers can end up tracking too many KPIs at once. When the KPI list grows past a few core metrics, attention spreads thin and weak signals get buried. That makes the scorecard less useful for action, especially when 2025 results must translate into clear moves on cost, margin, and cash.

Icon

Slow Feedback

Slow feedback is a real weakness in Arkema's Balanced Scorecard because chemical KPIs often update after the market has already moved. A 10% jump in raw materials or energy can hit margins in days, while scorecard reports may only catch up weeks later. That delay can hide demand shifts, so managers react too late.

Explore a Preview
Icon

Segment Mismatch

Segment mismatch is a real risk for Arkema because one scorecard can flatten very different businesses into one set of targets. Adhesives, advanced materials, and coatings do not move on the same cycle, and a 5% mix shift can change margins and cash flow far more in one unit than another. So the same KPI can look fine overall while hiding weak demand or pricing pressure in a specific segment.

Icon

ESG Measurement Friction

Arkema's 2025 ESG scorecard still faces friction because plant data do not line up cleanly across grids, fuels, and supplier methods. In chemicals, scope 3 often exceeds 70% of total emissions, so small method changes can shift the result more than the factory itself. That makes year-to-year and site-to-site comparison weaker, and it can blur how much of the 2025 sustainability gain is real.

Icon

Innovation Lag

Arkema's innovation model often needs several years to pay off, especially in advanced materials and specialty chemistries. A Balanced Scorecard that overweights quarterly sales or margin targets can miss the later cash flow from long-cycle R&D. That can understate the real value of programs that start as costs, then become higher-margin platforms.

Icon

Arkema's KPI overload can hide margin shocks and ESG risk

Arkema's scorecard can overtrack 3 segments and too many KPIs, so weak signals get lost. Chemical metrics also lag fast moves, and a 10% raw-material shock can hit margin before reports catch up.

One set of targets can blur Adhesives, Advanced Materials, and Coatings. That matters when a 5% mix shift can swing margin and cash more than the headline scorecard shows.

ESG and R&D are also hard to read: scope 3 can exceed 70% of emissions, and long-cycle innovation may need years before cash returns.

Drawback Key data
Too many KPIs 3 segments
Slow feedback 10% raw-material shock
ESG noise Scope 3 >70%

Get Your Copy
Arkema Reference Sources

This is the actual Arkema Balanced Scorecard analysis document you'll receive upon purchase – no surprises, just the full professional report. The preview below is taken directly from the complete file, so what you see here is exactly what you'll get. Purchase unlocks the full, detailed version immediately.

Explore a Preview

Frequently Asked Questions

It measures how well Arkema turns strategy into results across financial, customer, internal process, and learning goals. For a company with 3 segments, the most useful indicators are margin, cash conversion, on-time delivery, R&D pipeline progress, and emissions intensity. That combination shows whether growth, execution, and sustainability are moving together.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.